ATF Revises Form 4473, Restoring Gun Rights For Medical Cannabis Patients
Federal firearms form no longer treats medical marijuana users as unlawful drug users, reversing decades of Second Amendment restrictions.

Adult male practicing target shooting outdoors with pistol at a range.
Form 4473 Revision Removes Medical Marijuana Disqualification
ATF's proposed Form 4473 revision eliminates the blanket prohibition on firearm purchases by medical marijuana cardholders, reversing a policy enforced since the agency's 2011 open letter to federal firearms licensees. The current form asks applicants whether they're unlawful users of marijuana or other controlled substances. The revised version would carve out state-authorized medical use from that definition.
The change follows the Supreme Court's June 2024 ruling in Garland v. Range, which held that historical firearm regulations didn't support disarming individuals for non-violent conduct. ATF cited that precedent in its notice of proposed rulemaking published May 15, 2026.
Four Million Americans Affected By Current Prohibition
Approximately 4 million Americans hold active medical marijuana cards across 38 states and four territories, all of whom currently face federal prosecution for firearm possession under 18 U.S.C. § 922(g)(3). That statute prohibits gun ownership by any person who is an unlawful user of or addicted to any controlled substance.
ATF's 2011 guidance instructed firearms dealers to deny sales to anyone with a medical marijuana card, regardless of actual use. Simple enrollment triggered disqualification. The proposed form revision would require dealers to assess current unlawful use rather than program enrollment alone.
Legal Framework Shifts After DEA Rescheduling
The form change arrives six months after DEA finalized marijuana's rescheduling from Schedule I to Schedule III under the Controlled Substances Act, effective November 2025. Schedule III substances include anabolic steroids and ketamine, both carrying accepted medical use under federal law, which undermines the rationale for treating medical cannabis patients as prohibited persons.
ATF's notice explicitly references the rescheduling as a factor in its reconsideration. Medical marijuana now occupies the same federal drug schedule as codeine and buprenorphine, neither of which triggers automatic firearm disqualification. The agency noted this parallel in its 47-page proposal.
Recreational Users Remain Prohibited
The proposed revision applies only to state-authorized medical marijuana patients; recreational users in the 24 adult-use states would still face disqualification under the unlawful-user provision. ATF's draft language requires applicants to certify they aren't unlawful users of marijuana, with medical authorization serving as an affirmative defense.
The distinction creates a two-tier system. A Colorado resident with a medical card could purchase a firearm. A Colorado resident buying recreationally at the same dispensary could not. Enforcement will depend on state medical registries and dealer verification protocols ATF hasn't yet detailed.
Comment Period Open Through July 14
ATF set a 60-day comment period closing July 14, 2026, with final rule implementation expected by fourth quarter 2026. The agency received more than 12,000 comments in the first ten days, according to the Federal Register docket ATF-2026-0004.
Gun-rights groups including the Firearms Policy Coalition submitted comments supporting the change but urging broader relief for all cannabis users. The National Rifle Association hasn't yet filed a formal position. Medical marijuana advocacy organizations, including Americans for Safe Access, called the revision a necessary first step but insufficient given the 24-state adult-use landscape.
Implementation Challenges And State-Federal Tension
Firearms dealers will face new compliance burdens verifying medical marijuana cards against state registries, many of which are confidential under state privacy laws. ATF hasn't proposed a federal verification system. Dealers in states without centralized registries—including California and Maine—may lack tools to confirm medical authorization.
The proposed rule doesn't address the roughly 200,000 individuals denied firearm purchases since 2011 based solely on medical marijuana status. ATF hasn't announced a process for expunging those denials from the National Instant Criminal Background Check System. For comprehensive background on federal cannabis enforcement and gun rights, see the CannIntel topic hub on cannabis and gun rights.
The next signal: whether ATF's final rule includes a pathway for recreational users or maintains the medical-only carve-out. That decision will determine whether 4 million or 50 million Americans regain Second Amendment protections.
For complete background, history, and our ongoing coverage of this story:
Open the CannIntel topic hub →Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

Lawmakers Push IRS for Cannabis Tax Guidance After Rescheduling
Congressional members are calling on the IRS to issue immediate tax guidance for cannabis operators following the DEA's rescheduling decision.

ATF Revises Gun Form 4473, Opening Path for Medical Cannabis Patients
New ATF guidance removes blanket marijuana disqualification from federal firearms background check form.

Louisiana Joins Multi-State Lawsuit to Block DEA Marijuana Rescheduling
Attorney General Liz Murrill adds Louisiana to coalition challenging federal reclassification from Schedule I to Schedule III.
More from the newsroom

Multimillion-Dollar Queenbury Cannabis Facility Breaks Ground
A major cultivation and processing project in upstate New York moves forward after years of regulatory delays.

Curaleaf Loses Challenge to New Jersey Labor-Peace Mandate
Federal court upholds state requirement forcing cannabis operators to sign neutrality pacts with unions.

Bloom Cannabis Cites Ohio Hemp Ban as Validation for Licensed Market
Ohio MSO says state's intoxicating-hemp prohibition underscores regulatory advantage of adult-use dispensaries.